sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. recently filed an opening position disclosure under Rule 8.3 with the Irish Takeover Panel regarding its interests in Mural Oncology plc. The disclosure is part of compliance with takeover rules established in 2022.
As of May 21, 2025, Vanguard controls 772,921 ordinary shares, representing a 4.48% stake in Mural Oncology. This position involves no cash-settled or stock-settled derivatives.
On the dealings front, the group recorded a sale of 36 shares at a price of 2.76 USD per unit. No additional derivative transactions or new securities dealings were noted.
The disclosure mentions no indemnity, options, or agreements to influence dealings, nor were any supplemental forms attached. Details were confirmed by contact Shawn Acker on May 22, 2025.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.